If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
526.00    -4.00 (-0.75%)
Bid:
521.00
Ask:
534.00
Spread: 13.00 (2.495%)
Market Cap: £303.05m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

22 Jan 2026 07:00

RNS Number : 8619P
Mortgage Advice Bureau (Hldgs) PLC
22 January 2026
Β 

Β 

22 January 2026

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

Β 

Trading Update

Β 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), a leading technology-drivenΒ UKΒ mortgage network and broker, today issues a trading update for the year ended 31 December 2025, ahead of publishing its final results on 17 March 2026.

Β 

Year ended 31 December 2025

Group revenue increased by 19% to c.Β£318m (2024: Β£266.5m), and the Board expects to report Adjusted PBT of c.Β£35.8m, representing 12% growth on the equivalent period last year (2024:Β Β£32.0m). The Group has traded in line with expectations for the year.

Β 

The Group's number of mainstream advisers1 at 31 December 2025 was up 10% on the prior year end to 2,135 (31 December: 1,941), with 65% of this growth driven by organic expansion from firms already in MAB's network, and the balance reflecting new Appointed Representative ("AR") firms joining MAB. This marks the first year of material growth since 2022, signalling increased confidence in the outlook.

Β 

Adviser productivity continued to grow, with the average revenue per mainstream adviser for the period increasing to Β£157k, a 13% increase from 2024 (Β£139k). This is a considerable achievement, given many new joiners in the year will not reach full productivity until 2026.

Β 

As expected, refinancing activity strengthened through the second half of 2025 as a greater volume of fixed-rate products matured. The number of remortgages and Product Transfers completed by our ARs during the year was up 12% compared to 2024.

Β 

In the purchase segment, the year started strongly as buyers brought forward transactions ahead of changes to Stamp Duty relief. The anticipated autumn pick-up in purchase activity did not materialise, reflecting buyer caution in the long run-up to the Budget on 26 November 2025. Nevertheless, underlying demand remained resilient, supported by strong lending appetite, with around 33,000 mortgage products available - an all-time high2.

Β 

The Group increased its M&A activity during the year. In 2025, we acquired majority ownership of Heron - our AR firm with the highest adviser productivity - alongside Evolve and Meridian, our leading New Build sector businesses. We also invested in the expansion of First Mortgage in the South through the acquisitions of Lucra and London-based Kinleigh Financial Services. We also acquired a majority stake in UK MoneyMan, further strengthening our later-life lending proposition, and invested in a business with an extremely exciting future, The Mortgage Mum.

In addition, MAB acquired full ownership of Dashly, the technology and data company behind its mortgage monitoring and nurturing tool for Β£2.8m, reinforcing MAB's position at the forefront of a rapidly evolving market. The combined cash consideration of these transactions totalled Β£12.4m.

Β 

We welcome the Financial Conduct Authority's ("FCA") continued work to evolve the mortgage regulatory framework, including its December 2025 updates on the Mortgage Rule Review and its stated priorities for 2026. The regulators' focus on proportionate, pro-growth reform will positively support both borrowers' ability to access credit and the level of borrowing achievable.

Β 

Current trading and outlook

The impact of prior economic shocks is now receding for both borrowers and lenders, supporting a more stable operating environment. The Group has entered 2026 with good momentum and continues to trade in line with the Board's expectations.

Β 

The outlook for refinance lending is particularly strong: MAB's fixed-rate maturities are 19% higher in 2026, materially ahead of the overall refinancing market, which is estimated to increase by 3%3. We are also seeing a gradual normalisation in product preferences, with 2-year fixed-rate products accounting for a larger share than 5-year fixes. This shift has been supported by the easing of stress-testing and is further strengthening our refinance pipeline for 2027 and 2028.

Β 

After a lull in house purchase activity towards the end of 2025, we expect a modest release of pent-up demand in early 2026. With affordability metrics improving, lending rules easing in certain areas and enhanced access to credit, there is strong underlying support for a gradual and sustainable recovery in purchase transactions.

Β 

Capital Markets update

As previously announced, MAB will host a virtual Capital Markets update via webcast on 28 January 2026 at 15:00 GMT. The event will feature:

Β 

Β· Progress on MAB 2.0 strategic priorities outlined at the CMD in February 2025

Β· Harnessing technology, data and AI to boost adviser performance and Group efficiency

Β· Demonstration of MAB's platform

Β· Leveraging scale to enhance profitability

Β· Q&A session

Β 

If you would like to register your interest for the event, please contact Camarco onΒ mab@camarco.co.uk.

Β 

Main Market listing

MAB confirms that, further to the announcement of 23 September 2025, the Board intends to proceed with the move to the ESCC listing category of the Main Market of the London Stock Exchange (the "Main Market"). This move is expected to facilitate access to a broader group of investors and further enhance the Group's profile.Β Subject to FCA approval, MAB expects to complete the move to the Main Market in Q2 2026. Further updates will be provided as appropriate.

Β 

Peter Brodnicki, Founder and CEO of MAB, commented:

"MAB delivered a strong financial performance in 2025, and I am pleased that our ARs are capitalising on a buoyant refinancing market which gathered momentum in the second half of the year and offers significant opportunities in 2026 and beyond.

Β 

Optimism is returning among many of our ARs. It is particularly encouraging to see organic adviser numbers returning to meaningful growth, alongside improving adviser productivity and we see that trend continuing.

Β 

2025 was an active year for M&A, as we consolidated our holdings in a number of existing businesses and added some high-quality strategic investments to strengthen our proposition. In 2026 and 2027, we expect to focus on integration and on optimising the margins and profitability of businesses brought into the group, which much of the M&A last year will support.

Β 

Over the past five years, MAB has made record investments in people and in-house technology, building a strong platform to deliver on its ambitions. Since joining MAB as COO in September, Yaiza Luengo is already having the expected impact driving operational efficiency across the group. Her expertise in leveraging technology, data, and AI, to optimise performance and growthΒ will provide important leadership in what will be a period of significant opportunity for MAB that will be leading the digital transformation of our sector.

Β 

We remain focused on delivering our strategic priorities and medium-term growth targets, and my team and I look forward to updating investors on these topics at our Capital Markets update on 28 January."

Β 

[1] Twenty7tec.

Β 

2 Excludes directly authorised advisers, later life advisers without a mortgage and protection license, and advisers in the process of being onboardedΒ who are not yet able to trade.Β 

3 UK Finance Mortgage Market Forecasts, December 2025. Includes Product Transfers.

Β 

Β 

Β 

Enquiries:

Mortgage Advice Bureau (Holdings) plc

Via Camarco

Peter Brodnicki, Chief Executive Officer

Emilie McCarthy, Chief Financial OfficerΒ 

Yaiza Luengo, Chief Operating OfficerΒ 

Β 

Β 

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Jason Grossman / Francis North

Β 

Β 

+44 (0) 20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-SummonsΒ 

Β 

Β 

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Thomas Philpott / Rob Parker

Β 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Letaba Rimell

Β 

Β 

mab@camarco.co.uk

Investor Relations

Β 

Investor.relations@mab.org.uk

About MAB:

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers.Β 

Through its partner firms known as Appointed Representatives (ARs), MAB has over 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digitalΒ marketing and website solutions.

For more information, visitΒ www.mortgageadvicebureau.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFFFLILFILFIR
Date   Source Headline
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSBusiness Update
31st Jan 20253:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
15th Jan 202512:06 pmRNSDirector/PDMR Shareholding
14th Jan 20253:09 pmRNSBlock listing Interim Review
13th Jan 20259:19 amRNSHolding(s) in Company
31st Dec 202411:56 amRNSDirector/PDMR Shareholding
17th Dec 202411:40 amRNSDirectors' Shareholdings and PDMR notification
2nd Dec 202411:40 amRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSDirector/PDMR Shareholding
14th Nov 202411:09 amRNSDirector/PDMR Shareholding
13th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20247:00 amRNSNotice of Capital Markets Day
12th Nov 20249:14 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSAppointment of Nominated Adviser and Joint Broker
4th Nov 20249:09 amRNSDirectors' Shareholdings and PDMR notification
28th Oct 20249:43 amRNSNotification of Major Holdings
15th Oct 20242:47 pmRNSDirectors' Shareholdings and PDMR notification
4th Oct 202412:16 pmRNSDirectors' Shareholdings and PDMR Notification
2nd Oct 20245:15 pmRNSNotification of Major Holdings
30th Sep 20244:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Sep 202411:58 amRNSDirectors' Shareholdings and PDMR notification
30th Sep 20249:42 amRNSDirectors' Shareholdings and PDMR notification
25th Sep 20247:00 amRNSDirectors' Shareholdings and PDMR notification
24th Sep 20247:00 amRNSInterim Results
17th Sep 20241:44 pmRNSDirectors' Shareholdings and PDMR notification
17th Sep 20249:16 amRNSNotification of Major Holdings
30th Aug 20245:17 pmRNSDirectors' Shareholdings and PDMR notification
15th Aug 20243:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Jul 20245:35 pmRNSDirectors' Shareholdings and PDMR notification
25th Jul 20247:00 amRNSTrading Update
22nd Jul 20248:02 amRNSDirectors' Shareholdings and PDMR notification
22nd Jul 20247:00 amRNSDirectors' Shareholdings and PDMR notification
12th Jul 20241:19 pmRNSBlock listing Interim Review
1st Jul 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20241:57 pmRNSNotification of Major Holdings
25th Jun 20247:00 amRNSNotification of Major Holdings
21st Jun 20243:06 pmRNSNotification of Major Holdings
17th Jun 20245:49 pmRNSDirector/PDMR Shareholding
13th Jun 202412:39 pmRNSDirector/PDMR Shareholding and TVR
12th Jun 20244:46 pmRNSNotification of Major Holdings
4th Jun 20244:18 pmRNSNotification of Major Holdings
31st May 202410:36 amRNSDirectors' Shareholdings and PDMR notification
29th May 20247:00 amRNSRelated Party Transaction
28th May 20243:56 pmRNSNotification of Major Holdings
23rd May 20247:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.